Clinical Trials

38 enrolled

Rectal Neoplasms

NCT05176964 2023-09-25

Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer

Unknown

50 enrolled

Rectal Neoplasms

NCT04083365 2023-05-31

PANDORA

100 enrolled

Rectal Neoplasms

NCT02288195 2023-05-12

CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients

663 enrolled

Rectal Neoplasms

NCT02948348 2021-09-16

Study to Nivolumab Following Preoperative Chemoradiotherapy

Phase 1/2 Unknown

90 enrolled

Rectal Neoplasms

NCT03484221 2021-04-14

Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer

30 enrolled

Rectal Neoplasms

NCT04103697 2021-02-09

RuCorT-01

560 enrolled

Rectal Neoplasms

NCT04134897 2021-02-09

RuCorT-02

316 enrolled

Rectal Neoplasms

NCT04135313 2021-02-09

RuCorT-03

540 enrolled

Rectal Neoplasms

NCT04621370 2020-11-09

PRIME-RT

48 enrolled

Rectal Neoplasms

NCT04405206 2020-10-14

BJCC-R01

Unknown

54 enrolled

Rectal Neoplasms

NCT04340401 2020-07-09

Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen

25 enrolled

Rectal Neoplasms

NCT04296240 2020-03-05

Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer

119 enrolled

Rectal Neoplasms

NCT02919878 2018-08-13

Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal Cancer

25 enrolled

Rectal Neoplasms

NCT02942563 2018-01-03

Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

100 enrolled

Rectal Neoplasms

NCT01952951 2017-09-13

PREPARE

110 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT03042000 2017-02-03

Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.

Phase NA Unknown

1,200 enrolled

Rectal Neoplasms

NCT00058474 2016-03-23

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

1,608 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT02137356 2015-09-03

Selinexor Combined With Standard Chemoradiation as Neoadjuvant Treatment in Locally Advanced Rectal Cancer

Phase 1 Unknown

28 enrolled

Rectal Neoplasms

NCT01818973 2015-06-08

Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer

45 enrolled

Rectal Neoplasms

NCT01941979 2014-10-30

A Study Comparing Adjuvant Chemotherapy Versus Observation for Patients With Rectal Adenocarcinoma After Neoadjuvant Chemo-Radiotherapy Treatment.

309 enrolled

Rectal Neoplasms

NCT02268006 2014-10-20

BISER

50 enrolled

Rectal Neoplasms

NCT00795301 2014-01-14

A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab

74 enrolled

Neoplasms, Rectal Neoplasms

NCT00967655 2014-01-10

Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer

54 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT00482222 2013-01-23

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

340 enrolled

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT01671891 2012-08-24

Detection and Enumeration of Circulating Tumor Cells in Rectal Cancer

Unknown

100 enrolled

Neoplastic Cells, Circulating, Rectal Neoplasms

NCT00689702 2012-03-26

XERT

43 enrolled

Rectal Neoplasms

NCT00842686 2012-03-26

CRAB

60 enrolled

Rectal Neoplasms

NCT01064999 2012-03-14

A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Phase 2/3 Unknown

240 enrolled

Rectal Neoplasms

NCT01474187 2011-11-18

Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer

Phase 1 Unknown

60 enrolled

Rectal Neoplasms

NCT00544011 2011-06-27

Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

47 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00383695 2010-01-13

EXPERT-C

164 enrolled

Rectal Neoplasms, Colorectal Neoplasms

NCT00075556 2009-02-09

Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00303745 2008-07-24

Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

78 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00506844 2007-07-25

ERBIRIX

40 enrolled